Ulrike Haus

1.2k total citations
31 papers, 955 citations indexed

About

Ulrike Haus is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrike Haus has authored 31 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrike Haus's work include Bone health and treatments (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Ulrike Haus is often cited by papers focused on Bone health and treatments (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Ulrike Haus collaborates with scholars based in Germany, Switzerland and United States. Ulrike Haus's co-authors include M. Späth, L. Färber, T Stratz, Wolfgang Müller, Oliver Treeck, Birgit Wackwitz, Olaf Ortmann, S. Drechsler, Katja Schmidt and Klaus Jung and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ulrike Haus

31 papers receiving 908 citations

Peers

Ulrike Haus
Stephen J. Oliver United States
Pierre Bouchelouche Denmark
Susan Smith United States
Derek Zieker Germany
Gilles Edan France
H Häntzschel Germany
Takuroh Imamura Japan
Ivo W. Tremont‐Lukats United States
Kennard L. Thomas United States
Stephen J. Oliver United States
Ulrike Haus
Citations per year, relative to Ulrike Haus Ulrike Haus (= 1×) peers Stephen J. Oliver

Countries citing papers authored by Ulrike Haus

Since Specialization
Citations

This map shows the geographic impact of Ulrike Haus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Haus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Haus more than expected).

Fields of papers citing papers by Ulrike Haus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Haus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Haus. The network helps show where Ulrike Haus may publish in the future.

Co-authorship network of co-authors of Ulrike Haus

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Haus. A scholar is included among the top collaborators of Ulrike Haus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Haus. Ulrike Haus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haus, Ulrike, Regina Ebert, Jutta Meißner-Weigl, et al.. (2011). Effect of zoledronic acid exposure on Ki-67 expression and proliferation in MCF7 cells resistant to apoptosis induction.. Journal of Clinical Oncology. 29(15_suppl). e21129–e21129. 2 indexed citations
2.
Lein, Michael, Kurt Miller, Manfred Wirth, et al.. (2009). Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid. The Prostate. 69(6). 624–632. 32 indexed citations
3.
Kretzschmar, Albrecht, Salah‐Eddin Al‐Batran, Manfred Kindler, et al.. (2007). Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 Year. PubMed. 4(4). 203–210. 14 indexed citations
4.
Lein, Michael, Manfred P. Wirth, Kurt Miller, et al.. (2007). Serial Markers of Bone Turnover in Men with Metastatic Prostate Cancer Treated with Zoledronic Acid for Detection of Bone Metastases Progression. European Urology. 52(5). 1381–1387. 56 indexed citations
5.
Späth, M., T Stratz, L. Färber, Ulrike Haus, & D. Pongratz. (2004). Treatment of fibromyalgia with tropisetron – dose and efficacy correlations. Scandinavian Journal of Rheumatology. 33(sup119). 63–66. 17 indexed citations
6.
Stratz, T, Bernd L. Fiebich, Ulrike Haus, & Wolfgang Müller. (2004). Influence of tropisetron on the serum substance P levels in fibromyalgia patients. Scandinavian Journal of Rheumatology. 33(sup119). 41–43. 18 indexed citations
7.
Helisch, Andreas, Helmut Reber, Hans‐Georg Buchholz, et al.. (2004). Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 31(10). 1386–92. 102 indexed citations
8.
Späth, M., T Stratz, Gunther Neeck, et al.. (2004). Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scandinavian Journal of Rheumatology. 33(4). 267–270. 52 indexed citations
9.
Färber, L., Ulrike Haus, M. Späth, & S. Drechsler. (2004). Physiology and pathophysiology of the 5‐HT3receptor. Scandinavian Journal of Rheumatology. 33(sup119). 2–8. 70 indexed citations
10.
Mueller, Martin, Peter Paschka, Tanja Lahaye, et al.. (2004). Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.. Blood. 104(11). 1003–1003. 1 indexed citations
11.
12.
Kopp, Joachim, et al.. (2001). Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon ? in the treatment of metastatic renal cell carcinoma: a pilot study. Cancer Immunology Immunotherapy. 49(11). 613–620. 22 indexed citations
13.
Stratz, T, et al.. (2001). Fibromyalgia treatment with intravenous tropisetron administration.. PubMed. 27(3). 113–8. 28 indexed citations
14.
Färber, Lothar, et al.. (2000). Treatment of Fibromyalgia with Intravenous Application of Tropisetron. Journal of Musculoskeletal Pain. 8(4). 31–40. 2 indexed citations
15.
Sulkowski, U., Markus W. Büchler, P. Pederzoli, et al.. (1999). A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma. European Journal of Cancer. 35(13). 1805–1808. 12 indexed citations
16.
17.
Sulkowski, U., et al.. (1997). Regression of a Distal Bile Duct Carcinoma after Treatment with Octreotide for 6 Months. Digestion. 58(4). 407–409. 4 indexed citations
18.
Haus, Ulrike, et al.. (1997). Treatment of prolonged chemotherapy induced severe thrombocytopenia with recombinant human interleukin-3???a report on four cases. Anti-Cancer Drugs. 8(3). 288–292. 2 indexed citations
19.
Kienast, K, W. E. Aulitzky, L. Färber, et al.. (1996). Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo. Annals of Hematology. 73(5). 231–238. 10 indexed citations
20.
Klingebiel, Thomas, Rupert Handgretinger, Peter Bader, et al.. (1995). Autologous Transplantation with Peripheral Blood Stem Cells in Children and Young Adults After Myeloablative Treatment: Nonrandomized Comparison Between GM-CSF and G-CSF for Mobilization. Journal of Hematotherapy. 4(4). 307–314. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen J. Oliver Breakdown of academic impact, for papers by Pierre Bouchelouche Breakdown of academic impact, for papers by Susan Smith Breakdown of academic impact, for papers by Derek Zieker Breakdown of academic impact, for papers by Gilles Edan Breakdown of academic impact, for papers by H Häntzschel Breakdown of academic impact, for papers by Takuroh Imamura Breakdown of academic impact, for papers by Ivo W. Tremont‐Lukats Breakdown of academic impact, for papers by Kennard L. Thomas
Rankless by CCL
2026